Giant cell myocarditis due to coxsackie B2 virus infection

Cardiology (Switzerland)

Volumn 88, Issue 3, 1997, Pages 296-299

  Meyer, Thomas ^a   Grumbach, Isabella M ^a   Kreuzer, Heinrich ^a   Morguet, Andreas J ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Coxsackie virus; Giant cell; Myocarditis

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; AUTOIMMUNITY; CARDIOGENIC SHOCK; CASE REPORT; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; GIANT CELL; HEART MUSCLE CELL; HUMAN; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; SEROLOGY; VIRUS MYOCARDITIS;

EID: 0030947848     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177346     Document Type: Article

References (16)

1. Cooper LT. Berry GJ. Rizep M. Schroeder JS: Giant cell myocarditis. J Heart Lung Transpl 1995;14:394-401.
2. Davies MJ. Pomerance A, Teare RD: Idiopathic giant cell myocarditis. A distinctive clinico-pathological entity. Br Heart J 1975:37:192-195.
3. Davidol TR. Palacios I. Southern J. Fallon JT. Newell J. Dec GW: Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation 1991:83:953-961.
4. Nieminen MS, Salminen U-S. Taskinen E, Heikkila P. Partanen J: Treatment of serious heart failure by transplantation in giant cell myocarditis diagnosed by endomyocardial biopsy. J Heart Lung Transpl 1994; 13:543-545.
5. Laruelle C. Vanhacckc J. Van de Werf F. Fla-meng W, Verbeken E, Meyns B, Vermeersch P. de Geest H: Cardiac transplantation in giant cell myocarditis. A case report. Acta Cardiol 1994:3:279-286.
6. Kong G, Madden B. Spyrou N, Pomerance A. Mitchell A. Yacoub M: Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppression. Eur Heart J 1991;12:554-557.
7. Zhang S. Kodama M. Hanawa H. Izumi T. Shi-bala A, Masani F: Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis. J Am Coll Cardiol 1993:21: 1254-1260.
8. Cunningham MW. Antone SM. Gulizia JM, McManus BM, Fischctti VA. Gauntt CJ: Cytotoxic and viral neutralizing antibodies cross-react with streptococcal M protein, enteroviruses. And human cardiac myosin. Proc Natl Acad Sci USA 1992:89:1320-1324.
9. Kodama M. Malsumoto Y. Fujiwara M, Zhang S. Hanawa H. Itoh E. Tsuda T. Izumi T. Shiba-ta A: Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res 1991;69:1042-1050.
10. Burke JS. Medline NM, Katz A: Giant cell myocarditis and myositis associated with thymoma and myasthenia gravis. Arch Pathol 1969:88:359-366.
11. Whitehead R: Isolated myocarditis. Br Heart J 1965;27:220-222.
12. Izumi T. Kodama M. Shibata A: Experimental giant cell myocarditis induced by cardiac myosin immunization. Eur Heart J 1991:12:166-168.
13. Abelmann WH: Viral myocarditis and its sequelae. Annu Rev Med 1973;24:145-152.
14. Woodruff JF: Viral myocarditis. Am J Pathol 1980:101:427-479.
15. McManus BM. Kandolf R: Evolving concepts of cause, consequence, and control in myocarditis. Curr Opin Cardiol 1991;6:418-427.
16. Dôrries R. Ter Meulen V: Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique. J Gen Virol 1983:64:159-167.